+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drug Delivery Market - Global Forecast 2026-2032- Product Image
Topical Drug Delivery Market - Global Forecast 2026-2032- Product Image
Sale

Topical Drug Delivery Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4829843
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drug Delivery Market is projected to reach USD 210.41 Billion in 2026. It is expected to continue growing at a CAGR of 7.29%, reaching USD 322.13 Billion by 2032.

The topical drug delivery landscape is expanding as healthcare systems prioritize localized therapy, improved adherence, and alternatives to systemic exposure. Topical formulations, including creams, gels, ointments, foams, sprays, transdermal patches, medicated plasters, and film-forming systems, remain central to dermatology, pain management, hormone therapy, wound care, anti-infectives, and selected cardiovascular and neurologic indications.

Demand is supported by measurable demographic and clinical trends, including population aging reported by the United Nations, the high global burden of skin and subcutaneous diseases documented in Global Burden of Disease research, and rising use of outpatient and home-based care. For manufacturers, the market is moving from conventional semisolids toward advanced topical drug delivery systems that combine penetration enhancers, controlled-release polymers, nanocarriers, microneedles, and patient-friendly applicators to improve bioavailability, dosing consistency, and therapeutic adherence.

Transformative Shifts in the Topical Drug Delivery Landscape

The competitive landscape is being reshaped by three converging shifts: precision dermatology, regulatory modernization, and platform-based formulation science. Regulators such as the U.S. FDA and European Medicines Agency have increased expectations for topical product quality, in vitro release testing, in vitro permeation testing, and bioequivalence evidence, especially for complex generics and locally acting products.

At the same time, pharmaceutical developers are prioritizing lifecycle management through reformulations that improve skin feel, dosing convenience, stability, and adherence. Device-enabled delivery, including metered-dose topical systems and transdermal patches, is creating differentiation beyond the active pharmaceutical ingredient. The shift from product-only strategies to formulation-platform strategies is becoming a decisive factor for topical drug delivery companies seeking faster development cycles, stronger regulatory packages, and more defensible portfolios.

Cumulative Impact of Artificial Intelligence on Topical Drug Delivery

Artificial intelligence is becoming a cumulative force across topical drug delivery R&D, from excipient screening and molecule-solubility prediction to skin permeation modeling, stability assessment, and clinical trial optimization. Machine learning models can help narrow formulation variables, predict compatibility risks, and support quality-by-design workflows, reducing reliance on purely empirical development.

AI is also improving commercial execution. Digital dermatology tools, image-based lesion tracking, real-world adherence analytics, and pharmacovigilance signal detection can help align topical therapies with patient behavior and physician decision-making. While AI does not replace validated laboratory testing, clinical evidence, or regulatory review, it strengthens development productivity and accelerates insight generation when paired with controlled datasets, standardized skin models, validated endpoints, and compliant data governance.

Key Regional Insights for Topical Drug Delivery

Asia-Pacific is becoming a high-priority region for topical drug delivery due to expanding healthcare access, strong generic manufacturing capacity, rising dermatology demand, and growing clinical research activity across China, India, Japan, South Korea, Australia, and ASEAN markets. North America remains a major innovation and commercialization hub, supported by FDA product-specific guidance, advanced clinical research infrastructure, high prescription dermatology adoption, and established use of transdermal therapies for pain, hormone replacement, and chronic disease management.

Europe benefits from established pharmaceutical regulation, strong dermatology research, mature pharmacovigilance systems, and demand for evidence-based treatment across the European Union and the United Kingdom. Latin America shows increasing demand for affordable topical generics and branded dermatology products, with Brazil and Mexico serving as regional anchors due to large patient populations and retail pharmacy reach. The Middle East is investing in specialty care, private healthcare expansion, and hospital infrastructure, while Africa’s opportunity is linked to essential medicines access, infectious skin disease management, wound care needs, and scalable low-cost topical therapies suited to diverse healthcare settings.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as regional regulatory cooperation improves and manufacturers expand access to dermatology, pain, anti-infective, and wound-care products across fast-urbanizing healthcare systems. GCC countries are strengthening specialty healthcare infrastructure and favor high-quality imported and locally registered topical therapies, particularly in dermatology clinics, hospitals, and retail pharmacy channels supported by expanding private care.

The European Union remains influential because its regulatory standards shape global expectations for topical product quality, safety, bioequivalence, pharmacovigilance, and post-authorization monitoring. BRICS countries provide a powerful mix of manufacturing scale, large patient populations, public health programs, and government interest in affordable medicines, making them important for both supply and demand. G7 economies lead in advanced formulation science, intellectual property creation, clinical evidence generation, and reimbursement scrutiny, while NATO member markets overlap with many high-income healthcare systems that prioritize resilient pharmaceutical supply chains, regulated cross-border procurement, and secure access to essential medicines.

Key Country Insights in Topical Drug Delivery

The United States leads in topical drug delivery innovation because of its mature prescription dermatology environment, FDA guidance for complex topical generics, high clinical trial activity, and strong specialty pharmacy ecosystem. Canada supports demand through regulated access, public-private reimbursement models, and established dermatology care pathways, while Mexico and Brazil offer opportunities through large urban populations, expanding retail pharmacy networks, and demand for affordable topical medicines for skin disease, pain, and wound care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain provide established dermatology care pathways, high regulatory expectations, and strong adoption of evidence-based prescription therapies, while Russia remains a sizable market with localized registration, reimbursement, and supply considerations. China and India are central to scale, with China advancing regulatory reform and domestic innovation, and India leveraging global generic manufacturing strength, cost-efficient development, and broad access to topical medicines. Japan, Australia, and South Korea contribute through high clinical standards, aging populations, advanced healthcare infrastructure, and adoption of innovative dermatology and transdermal products.

Actionable Recommendations for Industry Leaders

Industry vendors should prioritize formulation platforms that can be reused across multiple molecules and indications, including semisolid systems, film-forming technologies, microneedles, liposomes, nanoemulsions, and polymer-based controlled-release approaches. Early investment in in vitro release testing, in vitro permeation testing, skin irritation and sensitization studies, stability programs, and human factor validation can reduce development risk and support regulatory confidence.

Organizations should also build AI-enabled formulation databases, diversify excipient and packaging suppliers, and align commercial strategies with regional reimbursement, prescribing behavior, climate-related stability requirements, and pharmacy channel dynamics. Partnerships with dermatology networks, contract development and manufacturing organizations, academic laboratories, and digital health providers can improve clinical evidence generation, patient adherence, lifecycle management, and market access for differentiated topical drug delivery products.

Research Methodology

This executive summary is based on a structured secondary research approach using publicly available and industry-recognized sources, including regulatory guidance from the U.S. FDA, EMA, national health agencies, pharmacopeial standards, peer-reviewed dermatology and pharmaceutical sciences literature, clinical trial registries, patent databases, and macroeconomic and demographic datasets from institutions such as the United Nations, World Bank, OECD, and WHO.

Insights were validated through triangulation across regulatory trends, technology adoption, therapeutic demand, manufacturing capabilities, healthcare access indicators, and regional policy signals. The analysis emphasizes verified qualitative and quantitative evidence rather than unsupported market claims, ensuring that conclusions remain suitable for strategic planning, SEO-focused industry communication, and evidence-based executive decision-making.

Conclusion

Topical drug delivery is transitioning from conventional skin-applied dosage forms to advanced, patient-centered therapeutic platforms. Momentum is supported by chronic disease management, dermatology demand, aging populations, outpatient care, and the need for safer localized delivery with improved adherence and reduced systemic exposure.

The strongest opportunities will emerge for organizations that integrate formulation science, regulatory evidence, AI-enabled development, robust quality systems, and regional access strategies. Stakeholders that can combine clinical credibility with scalable manufacturing, supply-chain resilience, and differentiated user experience will be best positioned to compete in the evolving topical drug delivery market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Topical Drug Delivery Market, by Product Type
7.1. Introduction
7.2. Creams
7.2.1. Oil In Water
7.2.2. Water In Oil
7.3. Gels
7.3.1. Hydrogel
7.3.2. Organogel
7.4. Ointments
7.4.1. Hydrophilic
7.4.2. Lipophilic
7.5. Patches
7.5.1. Multi Layer
7.5.2. Single Layer
8. Topical Drug Delivery Market, by Delivery Technology
8.1. Introduction
8.2. Active Delivery
8.3. Passive Delivery
9. Topical Drug Delivery Market, by Route of Administration
9.1. Introduction
9.2. Buccal
9.3. Dermal
9.4. Nasal
9.5. Ocular
9.6. Rectal
9.7. Vaginal
10. Topical Drug Delivery Market, by Formulation Type
10.1. Introduction
10.2. Liquids
10.3. Semi-solids
10.4. Solids
10.5. Sprays & Foams
11. Topical Drug Delivery Market, by Therapeutic Application
11.1. Introduction
11.2. Dermatology
11.2.1. Anti Bacterial
11.2.2. Anti Fungal
11.2.3. Anti Inflammatory
11.3. Hormone Replacement
11.3.1. Estrogen
11.3.2. Testosterone
11.4. Pain Management
11.4.1. Local Anesthetics
11.4.2. NSAIDs
12. Topical Drug Delivery Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
12.4.1. Inpatient
12.4.2. Outpatient
12.5. Retail Pharmacies
13. Topical Drug Delivery Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.2.1. Hospital Pharmacy
13.2.2. Retail Pharmacy
13.3. Online Pharmacies
14. Topical Drug Delivery Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Topical Drug Delivery Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Topical Drug Delivery Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. Canada
16.5. India
16.6. Japan
16.7. United Kingdom
16.8. Russia
16.9. Brazil
16.10. Italy
16.11. Mexico
16.12. France
16.13. Spain
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. 3M Company
18.2. AbbVie Inc.
18.3. Bausch Health Companies Inc.
18.4. Bayer AG
18.5. Crescita Therapeutics Inc.
18.6. DuPont de Nemours, Inc.
18.7. Element Materials Technology
18.8. Galderma SA
18.9. GlaxoSmithKline plc
18.10. Hisamitsu Pharmaceutical Co.,Inc.
18.11. Johnson & Johnson Services, Inc.
18.12. Kindeva Drug Delivery L.P.
18.13. LEO Pharma A/S
18.14. Lubrizol Corporation
18.15. MedPharm Group Ltd.
18.16. Merck & Co., Inc.
18.17. Novartis AG
18.18. Pfizer Inc.
18.19. Porex Corporation
18.20. Sun Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CREAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL OIL IN WATER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL OIL IN WATER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL OIL IN WATER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL WATER IN OIL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL WATER IN OIL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL WATER IN OIL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL GELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HYDROGEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HYDROGEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HYDROGEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ORGANOGEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ORGANOGEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ORGANOGEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HYDROPHILIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HYDROPHILIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HYDROPHILIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL LIPOPHILIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL LIPOPHILIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LIPOPHILIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MULTI LAYER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MULTI LAYER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MULTI LAYER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SINGLE LAYER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SINGLE LAYER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SINGLE LAYER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ACTIVE DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PASSIVE DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL BUCCAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BUCCAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BUCCAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL NASAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL NASAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL NASAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL OCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL OCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL OCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL RECTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL RECTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RECTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL VAGINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL VAGINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL VAGINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SEMI-SOLIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SEMI-SOLIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SEMI-SOLIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SOLIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SOLIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SOLIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SPRAYS & FOAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DERMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DERMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DERMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ANTI BACTERIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ANTI BACTERIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ANTI BACTERIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ANTI FUNGAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ANTI FUNGAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ANTI FUNGAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ANTI INFLAMMATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HORMONE REPLACEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ESTROGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ESTROGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ESTROGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TESTOSTERONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TESTOSTERONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL TESTOSTERONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL LOCAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 194. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 196. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 197. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 198. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 199. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 200. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 202. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 203. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 205. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 206. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 207. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 209. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 210. EUROPE TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 228. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 229. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 230. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 231. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 232. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 233. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 234. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 236. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 237. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 239. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 240. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 241. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 243. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 245. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 249. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 250. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 251. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 252. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 253. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 254. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 255. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 257. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 258. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 259. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 261. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. ASEAN TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 263. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 264. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 266. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 267. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 268. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 269. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 271. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 272. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 274. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 275. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 276. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 278. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 279. GCC TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 297. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 298. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 300. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 301. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 302. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 303. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 304. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 305. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 306. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 308. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 309. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 310. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 312. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 313. BRICS TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 314. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 315. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 317. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 318. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 319. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 320. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 321. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 322. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 323. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 325. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 326. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 327. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 329. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 330. G7 TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 331. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 332. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 333. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 334. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 335. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 336. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 337. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 338. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 339. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 340. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 341. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 342. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 343. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 344. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 346. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 347. NATO TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 348. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 349. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 350. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 351. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2017-2032 (USD MILLION)
TABLE 352. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2017-2032 (USD MILLION)
TABLE 353. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2017-2032 (USD MILLION)
TABLE 354. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PATCHES, 2017-2032 (USD MILLION)
TABLE 355. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DELIVERY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 356. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2017-2032 (USD MILLION)
TABLE 359. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMATOLOGY, 2017-2032 (USD MILLION)
TABLE 360. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HORMONE REPLACEMENT, 2017-2032 (USD MILLION)
TABLE 361. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 362. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 364. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 365. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 366. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 367. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PROD

Companies Mentioned

  • 3M Company
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Crescita Therapeutics Inc.
  • DuPont de Nemours, Inc.
  • Element Materials Technology
  • Galderma SA
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery L.P.
  • LEO Pharma A/S
  • Lubrizol Corporation
  • MedPharm Group Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Porex Corporation
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 210.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 322.13 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Topical Drugs Market - Global Forecast 2026-2032 - Product Image

Topical Drugs Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Compounded Topical Drug Market - Global Forecast 2026-2032 - Product Image

Compounded Topical Drug Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 238 Pages
  • Global
From
Topical Drug Delivery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Topical Drug Delivery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Topical Drug Delivery Market Report 2026 - Product Image

Topical Drug Delivery Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Topical Drug Delivery Market

The Topical Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the body through various methods. Topical Drug Delivery involves the application of drugs to the skin, mucous membranes, or other external surfaces of the body. This method of drug delivery is advantageous because it allows for localized delivery of drugs, which can reduce systemic side effects and improve patient compliance. Additionally, topical drug delivery can be used to deliver drugs to specific areas of the body, such as the eyes, ears, and nose. The Topical Drug Delivery market is composed of a variety of companies, including Galderma, Mylan, and Perrigo. These companies specialize in the development and manufacture of topical drug delivery systems, such as creams, ointments, gels, and patches. Additionally, many of these companies offer services such as formulation development, clinical trial support, and regulatory affairs. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.